Login / Signup

Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry.

Tom DixonDerek MacPhersonBarmak MostofianTaras DauzhenkaSamuel D LotzDwight McGeeSharon ShechterUtsab R ShresthaRafal WiewioraZachary A McDarghFen PeiRajat PalJoão V RibeiroTanner WilkersonVipin SachdevaNing GaoShourya JainSamuel SparksYunxing LiAlexander VinitskyXin ZhangAsghar M RazaviIstván KolossváryJason ImbriglioArtem EvdokimovLouise BergeronWenchang ZhouJagat AdhikariBenjamin RuprechtAlex DicksonHuafeng XuWoody ShermanJesus A Izaguirre
Published in: Nature communications (2022)
Targeted protein degradation (TPD) is a promising approach in drug discovery for degrading proteins implicated in diseases. A key step in this process is the formation of a ternary complex where a heterobifunctional molecule induces proximity of an E3 ligase to a protein of interest (POI), thus facilitating ubiquitin transfer to the POI. In this work, we characterize 3 steps in the TPD process. (1) We simulate the ternary complex formation of SMARCA2 bromodomain and VHL E3 ligase by combining hydrogen-deuterium exchange mass spectrometry with weighted ensemble molecular dynamics (MD). (2) We characterize the conformational heterogeneity of the ternary complex using Hamiltonian replica exchange simulations and small-angle X-ray scattering. (3) We assess the ubiquitination of the POI in the context of the full Cullin-RING Ligase, confirming experimental ubiquitinomics results. Differences in degradation efficiency can be explained by the proximity of lysine residues on the POI relative to ubiquitin.
Keyphrases